SIG
IDXX icon

Stanford Investment Group’s Idexx Laboratories IDXX Stock Holding History

Stanford Investment Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-249
Closed -$23K – 410
2016
Q2 		$23K Sell
249
-77
-24% -$6.61K 0.01% 231
2016
Q1 		$26K Hold
326
– – 0.01% 213
2015
Q4 		$24K Hold
326
– – 0.01% 203
2015
Q3 		$24K Hold
326
– – 0.02% 203
2015
Q2 		$21K Buy
326
+70
+27% +$4.85K 0.02% 220
2015
Q1 		$20K Buy
+256
New +$19.9K 0.02% 230

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Stanford Investment Group's IDXX Position: Q3 2016 in Review

Stanford Investment Group sold out of Idexx Laboratories (IDXX) in Q3 2016, closing a stake of 249 shares — an estimated $23K sold.

Stanford Investment Group first reported a position in IDXX in Q1 2015 and held it in 6 quarters. The position peaked at $26K in Q1 2016. 483 funds tracked by Wall St. Rank hold IDXX as of Q3 2016.

  • Stanford Investment Group reported no remaining Idexx Laboratories position as of Q3 2016 after selling out during the quarter.
  • Stanford Investment Group sold 249 Idexx Laboratories shares in Q3 2016, an estimated $23K.
  • Stanford Investment Group first reported a position in Idexx Laboratories in Q1 2015 and held it in 6 quarters.
  • Stanford Investment Group's Idexx Laboratories position peaked at $26K in Q1 2016.
  • 483 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2016.

Based on Stanford Investment Group's 13F filing for Q3 2016, filed 10 Nov 2016.